Bristol Myers Squibb presents data across targeted protein degradation research at EHA 2025
Innovative agents highlight growth of targeted protein degradation platform and BMS' leadership in innovative cancer therapies
Innovative agents highlight growth of targeted protein degradation platform and BMS' leadership in innovative cancer therapies
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
The trial targets MCAS/MCAD, an under-recognized, debilitating condition with an unknown cause and no cure
Approximately 35% of male cancer patients and 12% of female cancer patients at Paras Health were diagnosed with tobacco-related cancers
Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs
The portfolio consists of liquids and immediate release solid orals which are in the therapeutic segment to treat infections associated with UTIs
Phytonadione Injectable Emulsion possesses the same type and degree of activity as does naturally-occurring vitamin K
Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74
Sun Pharma has been involved in a patent infringement case with Incyte Corporation over LEQSELVI
In light of the contributions of these three institutes, it was decided to organize a CSIR Startup Conclave in Hyderabad. The event, scheduled for April 22–23, 2025
Subscribe To Our Newsletter & Stay Updated